1041 related articles for article (PubMed ID: 12730799)
1. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Boivin G; Meunier PJ
Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
[TBL] [Abstract][Full Text] [Related]
2. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
[TBL] [Abstract][Full Text] [Related]
3. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration.
Boivin G; Deloffre P; Perrat B; Panczer G; Boudeulle M; Mauras Y; Allain P; Tsouderos Y; Meunier PJ
J Bone Miner Res; 1996 Sep; 11(9):1302-11. PubMed ID: 8864905
[TBL] [Abstract][Full Text] [Related]
4. Effects of bisphosphonates on matrix mineralization.
Boivin G; Meunier PJ
J Musculoskelet Neuronal Interact; 2002 Dec; 2(6):538-43. PubMed ID: 15758388
[TBL] [Abstract][Full Text] [Related]
5. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
6. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment.
Roschger P; Manjubala I; Zoeger N; Meirer F; Simon R; Li C; Fratzl-Zelman N; Misof BM; Paschalis EP; Streli C; Fratzl P; Klaushofer K
J Bone Miner Res; 2010 Apr; 25(4):891-900. PubMed ID: 20437609
[TBL] [Abstract][Full Text] [Related]
7. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
[TBL] [Abstract][Full Text] [Related]
9. The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography.
Boivin G; Meunier PJ
Calcif Tissue Int; 2002 Jun; 70(6):503-11. PubMed ID: 12019458
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term treatment with strontium ranelate on bone strontium content.
Bärenholdt O; Kolthoff N; Nielsen SP
Bone; 2009 Aug; 45(2):200-6. PubMed ID: 19376283
[TBL] [Abstract][Full Text] [Related]
11. In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization.
Boivin G; Farlay D; Khebbab MT; Jaurand X; Delmas PD; Meunier PJ
Osteoporos Int; 2010 Apr; 21(4):667-77. PubMed ID: 19597910
[TBL] [Abstract][Full Text] [Related]
12. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
14. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.
Li C; Paris O; Siegel S; Roschger P; Paschalis EP; Klaushofer K; Fratzl P
J Bone Miner Res; 2010 May; 25(5):968-75. PubMed ID: 19874195
[TBL] [Abstract][Full Text] [Related]
15. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
16. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
17. Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX).
Roschger P; Lombardi A; Misof BM; Maier G; Fratzl-Zelman N; Fratzl P; Klaushofer K
J Bone Miner Res; 2010 Jan; 25(1):48-55. PubMed ID: 19580465
[TBL] [Abstract][Full Text] [Related]
18. Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.
Doublier A; Farlay D; Khebbab MT; Jaurand X; Meunier PJ; Boivin G
Eur J Endocrinol; 2011 Sep; 165(3):469-76. PubMed ID: 21690207
[TBL] [Abstract][Full Text] [Related]
19. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
Kaliterna DM
Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
[TBL] [Abstract][Full Text] [Related]
20. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
Fratzl P; Roschger P; Eschberger J; Abendroth B; Klaushofer K
J Bone Miner Res; 1994 Oct; 9(10):1541-9. PubMed ID: 7817799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
